NFYA Antibody

中文名稱：

NFYA兔多克隆抗體
貨號：

CSB-PA288741
規(guī)格：

￥2024
圖片：
Western blot analysis of extracts from 293 cells, HepG2 cells and COLO205 cells, using NFYA antibody.
其他：

產(chǎn)品詳情
產(chǎn)品評價
引用文獻(xiàn)
相關(guān)產(chǎn)品
靶點詳情

產(chǎn)品詳情

產(chǎn)品名稱：

Rabbit anti-Homo sapiens (Human) NFYA Polyclonal antibody
Uniprot No.：

P23511
基因名：

NFYA
宿主：

Rabbit
反應(yīng)種屬：

Human,Mouse,Rat
免疫原：

Synthesized peptide derived from internal of Human NFYA.
免疫原種屬：

Homo sapiens (Human)
克隆類型：

Polyclonal
純化方式：

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
濃度：

It differs from different batches. Please contact us to confirm it.
產(chǎn)品提供形式：

Liquid
應(yīng)用范圍：

ELISA,WB

推薦稀釋比：

Application	Recommended Dilution
WB	1:500-1:3000

Protocols：

ELISA Protocol
Western Blotting (WB) Protocol
儲存條件：

Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
貨期：

Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
用途：

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

引用文獻(xiàn)

Coptisine-mediated downregulation of E2F7 induces G2/M phase arrest in hepatocellular carcinoma cells through inhibition of E2F4/NFYA/NFYB transcription factors H Wang,Chemico-biological interactions,2024

產(chǎn)品評價

靶點詳情

功能：

Component of the sequence-specific heterotrimeric transcription factor (NF-Y) which specifically recognizes a 5'-CCAAT-3' box motif found in the promoters of its target genes. NF-Y can function as both an activator and a repressor, depending on its interacting cofactors. NF-YA positively regulates the transcription of the core clock component ARNTL/BMAL1.
基因功能參考文獻(xiàn)：
1. Results from a study on gene expression variability markers in early-stage human embryos shows that NFYA is a putative expression variability marker for the 3-day, 8-cell embryo stage. PMID: 26288249
2. Our results identified for the first time one of the mechanisms responsible for NF-Y expression, which may be involved in the aberrant expression and activity observed in tumor cells and other pathological conditions. PMID: 29505822
3. Suggest NF-YAs and lamin A expression levels as novel potential biomarkers useful to identify G1 endometrial carcinoma patients with risk of recurrence. PMID: 27974701
4. increased expression of NF-YA may promote a malignant phenotype in OS cells via modulation of FASN expression. PMID: 27840951
5. The findings indicate that overexpression of NF-YA contributes to tumor angiogenesis through EZH2-STAT3 signaling in human melanoma cells, highlighting NF-YA as a potential therapeutic target in human melanoma. PMID: 27109360
6. Data indicate that specific cancer-driving nodes are generally under NF-YA/B control. PMID: 26646448
7. Presence of NF-Y transcription factor plays a pivotal role in transcriptional regulation of ID genes in development. PMID: 26509926
8. our results indicate that NF-YA alternative splicing is an influential muscle cell determinant, through direct regulation of selected cell cycle blocking genes, and, directly and indirectly, of muscle-specific transcription factors PMID: 26921500
9. A direct non-transcriptional role of NF-Y in the overall efficiency of DNA replication, specifically in the DNA elongation process. PMID: 26732297
10. enhanced CDCA8 promoter activities by NF-Y overexpression and reduced CDCA8 transcription by NF-Y knockdown further verified that NF-Y is a positive regulator of CDCA8 transcription. PMID: 26170459
11. Data show that Zinc-fingers and homeoboxes 2 (ZHX2) represses nuclear transcription factor Y alpha (NF-Y)-mediated activation of multidrug resistance 1 (MDR1) transcription. PMID: 25473899
12. NF-Y inhibits NT2/D1 cell growth in p53-independent manner and decreases SOX2 expression. PMID: 25756534
13. Stimulation of the lymphocytes with phytohemagglutinin, restores normal OGG1 levels and repair rates. MAP kinase c-Jun N-terminal kinase (JNK) and the recruitment of the transcription factor NFYA to the promoter region of OGG1 are shown to be involved. PMID: 25463392
14. Association of p21 with NF-YA suppresses the expression of PLK1 and prevents mitotic death in response to DNA damage. PMID: 24407240
15. NF-YA binds directly over the CCAAT sequence. PMID: 23595228
16. NF-Y recruits the developmentally regulated, erythroid transcription activator GATA-2 and general repressor BCL11A to modulate transcription of the gamma-globin gene. PMID: 23071749
17. The crystal structure of NF-Y bound to a 25 bp CCAAT oligonucleotide shows that the histone-fold domains dimer binds to the DNA sugar-phosphate backbone, mimicking the nucleosome H2A/H2B-DNA assembly; NF-YA both binds to NF-YB/NF-YC and inserts an alpha helix deeply into the DNA minor groove, providing sequence-specific contacts to the CCAAT box. PMID: 23332751
18. NFYA could be a target of mutant TBP in SCA17. PMID: 22530004
19. This study unveils a new role for NF-Y in the regulation of human proteasome genes. PMID: 22285817
20. Sp1, CREB, HNF-1, and NF-Y, known to be responsive to hormones and diet, regulate NAGS transcription PMID: 22383952
21. Findings establish that NF-Y acts upstream of E2F1 in p53-mediated apoptosis. PMID: 20952509
22. A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. PMID: 20630860
23. The phospho-DeltaNp63alpha forms protein-protein complexes with NF-YA transcription factor regulate the transcription of DDIT3 gene implicated in the programmed cell death of head and neck squamous cell carcinoma cells upon cisplatin exposure. PMID: 20023394
24. the immediate-early ICP0 gene may be among the first genes to be induced during the early events in HSV-1 reactivation, and NF-Y is important for this induction, and other factors induce the ICP22 promoter. PMID: 19828605
25. immunodepletion of Oct-1 and NF-YA proteins or mutations in the OCT-1 and CAAT motifs disrupt BRCA1 binding to the GADD45 promoter PMID: 11777930
26. NF-YA increases during CaCo-2 differentiation and that the constitutive expression of NF-YA, obtained in stably transfected CaCo-2 cells, results in the expression of differentiation markers PMID: 12392713
27. confirms the important transactivating role of NF-YA isoforms for the cystathionine beta synthase 1b promoter via its synergism with Sp1 PMID: 12427542
28. p300 binds to multiple NF-Y trimers to regulate cyclin B2 promoter function PMID: 12482752
29. role in inhibiting von Willebrand factor promoter activation through recruitment of histone deacetylases PMID: 12511565
30. NF-Y is a developmentally regulated inducer of the HOXB4 gene in hematopoietic cells. PMID: 12791656
31. NF-YA is phosphorylated in a pathway involving Cdk2 PMID: 12857729
32. Histone deacetylase inhibitors can induce Gadd45 through its promoter without the need for functional p53, and both Oct-1 and NF-Y concertedly participate in trichostatin A-induced activation of the gadd45 promoter. PMID: 14586402
33. NF-YA has a role in regulating the induction of human OGG1 following administration of DNA-alkylating agents PMID: 14688259
34. p53 negatively regulates Chk2 gene transcription through modulation of NF-Y function and that this regulation may be important for reentry of cells into the cell cycle after DNA damage is repaired. PMID: 15044452
35. NF-Y has a role in regulating EPHX1 expression through its interaction with C/EBPalpha PMID: 15150264
36. transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex are induced by Trichostatin A PMID: 15647279
37. These results indicate that 1,25(OH)2D3 may affect transcription of the human PTH gene both by competitive binding of VDR and NF-Y, and by modulating transcriptional activity of NF-Y. PMID: 15707954
38. NF-Ya is a potent cellular regulator of hematopoietic stem cell self-renewal PMID: 16081537
39. Data suggest that the cell specifity of HIV-1 expression and replication may be regulated, in part, through the control of TRBP1 expression by NF-Y factors. PMID: 16343534
40. cyclin B2 expression in colorectal adenocarcinoma is dependent on NF-Y PMID: 17289878
41. Our data indicate that multiple CCAAT control elements are involved in the regulation of the SOX3 promoter, suggesting that NF-Y functions as a key regulator of SOX3 gene expression. PMID: 17910945
42. NF-Y is an important mediator of EBV stress response in switching from a latent to lytic state PMID: 18281530
43. p53 overexpression strongly downregulates the transcriptional efficiency driven by an H ferritin promoter construct containing only the NF-Y recognition sequence. PMID: 18372207
44. NF-Y is a fundamental switch at the heart of decision between gene activation and repression in CCAAT regulated genes. PMID: 18446193
45. Transcription factors Sp3, ZBP-89 and NF-Y are capable of binding to the SOX18 promoter region. PMID: 18496767
46. The existence of a functional binding site for the tumor suppressor p53 near the proximal CCAAT box and the fact that the basal expression of annexin A1 in human colon adenocarcinoma cells is driven by p53 at the transcriptional level, is shown. PMID: 18541673
47. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PMID: 18654640
48. O-GlcNAc of Sp1 serine/threonine-rich region interrupts a physical interaction between Sp1 and NF-YA, thus inhibiting Sp1-NF-Y cooperative activation of gene transcription. PMID: 19302979
49. review: role of the C/EBPbeta isoforms in breast cancer PMID: 19351437
50. NF-Y (complex of NFYA, NFYB, and NFYC) was initially described as the factor binding to the Y box of MHC class II genes, an essential element of MHC class II gene enhancers and promoters. PMID: 3476205
顯示更多

收起更多
亞細(xì)胞定位：

Nucleus.
蛋白家族：

NFYA/HAP2 subunit family
數(shù)據(jù)庫鏈接：

HGNC: 7804

OMIM: 189903

KEGG: hsa:4800

STRING: 9606.ENSP00000345702

UniGene: Hs.10441

Most popular with customers

YWHAG Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
YWHAB Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF, FC

Species Reactivity: Human, Mouse, Rat
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
XRCC5 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC, IF

Species Reactivity: Human
XPNPEP1 Recombinant Monoclonal Antibody

Applications: ELISA, IHC, FC

Species Reactivity: Human
XDH Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WT1 Recombinant Monoclonal Antibody

Applications: ELISA, WB, IHC

Species Reactivity: Human
WFDC2 Recombinant Monoclonal Antibody

Applications: ELISA, WB, FC

Species Reactivity: Human